Clinical Trial Update: Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

View source ↗

Summary

A completed clinical trial evaluating cancer outcomes in patients treated with dapagliflozin in addition to other antidiabetic therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer, Bladder Cancer | Status: COMPLETED